Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-μg) diffusion methods
- 30 April 1999
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 33 (4) , 247-253
- https://doi.org/10.1016/s0732-8893(98)00086-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparative in-vitro and in-vivo activity of AM-1155 against anaerobic bacteria.Journal of Antimicrobial Chemotherapy, 1997
- Comparison of the antibacterial activities of the quinolones Bay 12- 8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [published erratum appears in J Antimicrob Chemother 1998 Jun;41(6):672]Journal of Antimicrobial Chemotherapy, 1997
- In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia sppAntimicrobial Agents and Chemotherapy, 1997
- Comparison of in vitro Antimicrobial Activity of AM-1155 with Those of Tosufloxacin and Fleroxacin against Clinical Isolates of Neisseria gonorrhoeae Harboring Quinolone Resistance Alterations in GyrA and ParCChemotherapy, 1997
- Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humansAntimicrobial Agents and Chemotherapy, 1995
- Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in JapanAntimicrobial Agents and Chemotherapy, 1995
- In-vitro and in-vivo activity of a new quinolone AM-1155 against Mycoplasma pneumoniaeJournal of Antimicrobial Chemotherapy, 1994
- Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacinAntimicrobial Agents and Chemotherapy, 1993
- In Vitro Activities of AM-1155 against Chlamydia spp. and M. avium ComplexDrugs, 1993
- In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinoloneAntimicrobial Agents and Chemotherapy, 1992